Bausch + Lomb’s ONE by ONE Recycling program helps prevent small, often overlooked eye health materials from entering landfills and waterways Program highlights the ongoing efforts...
Increased cutting speed of 25,000 cuts per minute 1 is designed to minimize retinal traction, 2 increase vitreous flow, 1 and reduce infusion pressure...
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and events...
Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April...
3 Reasons BLCO is Risky and 1 Stock to Buy Instead
Both primary effectiveness endpoints were met, demonstrating statistically significant and clinically meaningful intraocular pressure reduction. ELIOS is an implant-free procedure that...